These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20216425)

  • 1. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.
    Hoffman RM; Black V; Technau K; van der Merwe KJ; Currier J; Coovadia A; Chersich M
    J Acquir Immune Defic Syndr; 2010 May; 54(1):35-41. PubMed ID: 20216425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal time on HAART for prevention of mother-to-child transmission of HIV.
    Chibwesha CJ; Giganti MJ; Putta N; Chintu N; Mulindwa J; Dorton BJ; Chi BH; Stringer JS; Stringer EM
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):224-8. PubMed ID: 21709566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.
    Katz IT; Shapiro R; Li D; Govindarajulu U; Thompson B; Watts DH; Hughes MD; Tuomala R
    J Acquir Immune Defic Syndr; 2010 May; 54(1):27-34. PubMed ID: 20065861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.
    European Collaborative Study
    Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.
    Black V; Hoffman RM; Sugar CA; Menon P; Venter F; Currier JS; Rees H
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):276-81. PubMed ID: 18845949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
    van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
    J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.
    Joao EC; Gouvêa MI; Menezes JA; Sidi LC; Cruz ML; Berardo PT; Ceci L; Cardoso CA; Teixeira Mde L; Calvet GA; Matos HJ
    Int J STD AIDS; 2012 Jan; 23(1):44-7. PubMed ID: 22362687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of revised PMTCT guidelines: a view from a public sector ARV clinic in Cape Town, South Africa.
    Van Schalkwyk M; Andersson MI; Zeier MD; La Grange M; Taljaard JJ; Theron GB
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):234-8. PubMed ID: 23422849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis.
    Moyo F; Haeri Mazanderani A; Sherman GG; Kufa T
    S Afr Med J; 2022 Mar; 112(3):219-226. PubMed ID: 35380525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.